NIH-funded research Career grant

Understanding how liver macrophages clear dead liver cells in NASH

Official title: Clearance of Dead Hepatocytes by Liver Macrophages in NASH

Funded at Columbia University Health Sciences · NIH-10876314 · Data updated 2026-11-12

This study is looking at how certain immune cells in the liver help remove dead liver cells in people with non-alcoholic steatohepatitis (NASH), a serious liver condition, to find new ways to treat the disease and improve liver health.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 1, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$90,000
NIH project number5K99DK137021-02
Project IDNIH-10876314 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with non-alcoholic steatohepatitis (NASH).

Less likely to help

Patients with liver diseases other than NASH or those without liver conditions may not benefit from this research.

What this research studies

This research investigates the role of liver macrophages in clearing dead liver cells in patients with non-alcoholic steatohepatitis (NASH), a serious liver disease. The study focuses on understanding how the failure to clear these dead cells contributes to liver damage and fibrosis. By examining the mechanisms of cell clearance, particularly the differences between apoptotic and necroptotic liver cells, the research aims to identify potential new therapeutic targets. Patients may benefit from insights that could lead to the development of effective treatments for NASH.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for NASH, improving liver health and patient outcomes.

How similar studies have gone: While the specific mechanisms of macrophage clearance in NASH are not well-studied, similar approaches in other diseases have shown promise in understanding cell death and clearance.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Shi, Hongxue — Columbia University Health Sciences
  • Study coordinator: Shi, Hongxue

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.